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It was previously reported that integrins a2b1, a4b1, and aXb2 are involved in rotavirus cell infection. In this work we
studied the role of integrin subunits a2, a4, and b2 on the attachment of rotaviruses RRV and nar3 to MA104 cells. Integrin
a2b1 was found to serve as the binding receptor for the neuraminidase-resistant virus nar3, whereas the neuraminidase-
sensitive strain RRV interacted with this integrin at a postattachment step. It was shown that nar3 binds a2b1 through the
DGE integrin-recognition motif located in the virus surface protein VP5. Integrin subunits a4 and b2 do not seem to be

















oRotaviruses have a genome of 11 segments of double-
stranded RNA contained in a triple-layered protein cap-
sid. The smooth external surface of the virus is made of
trimers of the glycoprotein VP7, while 60 spike-like struc-
tures, formed by dimers of VP4, protrude from this sur-
face (6). VP4 has essential functions during the early
interactions of the virus with the cell; it is used as the
virus attachment protein (12, 17), and it is also important
or virus entry, since for the virus to penetrate into the
ell’s cytoplasm VP4 has to be cleaved by trypsin into
wo subunits, VP5 and VP8 (2).
The cell attachment of some rotavirus strains isolated
rom animals (other than humans), including rhesus ro-
avirus RRV, is greatly diminished by treatment of cells
ith neuraminidase (NA), indicating the need for sialic
cid (SA) on the cell surface. However, the interaction of
hese strains with a SA-containing receptor does not
eem to be essential, since variants which no longer
eed SA to infect the cells have been isolated from RRV
nd from the simian rotavirus strain SA11 (3, 12, 14).
The binding of RRV to sialic acids has been shown to
e mediated by VP8, and the domain of the protein
nvolved in this binding was previously described (7, 10).
n the other hand, the NA-resistant RRV variant nar3
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50as found to attach to cells through the VP5 trypsin
leavage product of VP4 (17), although the region of VP5
esponsible for this interaction and the cell molecule that
unctions as receptor for the virus have not yet been
etermined.
Recently, it was reported that the VP5 subunit of VP4
ontains the tripeptide-sequence motifs DGE and IDA,
hich are known to interact with integrins a2b1 and
a4b1, respectively, while VP7 contains the aXb2 integrin
ligand site GPR, and the a4b1-binding motif LDV (4, 9). It
as also shown that antibodies to integrin subunits a2,
a4, and b2, as well as peptides that mimic the ligand
ites for these integrins, blocked the infectivity of the
A-sensitive simian rotavirus strain SA11 and of the
A-resistant human rotavirus strain RV5. We recently
escribed that antibodies to these three integrin sub-
nits, and to integrin avb3, are able to block the infec-
ivity of rotaviruses RRV and nar3, as well as that of
uman rotavirus strain Wa, and we showed that integrin
avb3 interacts with these three rotavirus strains at a
ostattachment step (8). In this work we studied the role
f integrins a2, a4, and b2 on the cell attachment of
rotaviruses RRV and nar3. We found that integrin a2b1
serves as the attachment receptor for the NA-resistant
rotavirus strain nar3, through the interaction with the
DGE motif present in the VP5 protein of the virus. This
integrin was found to interact with RRV at a postattach-
ment step, similar to integrin subunits a4 and b2, which
did not function as primary binding sites for these two
viruses.
The infectivity and cell-binding blocking assays em-





















































51RAPID COMMUNICATIONscribed (11). For the infectivity assay, MA104 cells in
96-well plates were preincubated with MAbs P1E6 to a2,
MHM23 to b2, P4G9 to a4 (Dako, Carpinteria, CA), or
FB12 to a1 (Chemicon, Temecula, CA), for 1 h at 37°C
nd the cells were then infected with 2000 focus-forming
nits (FFUs) of either RRV or nar3 viruses. After a virus
dsorption period of 1 h at 37°C, the cells were washed
nd the infection was allowed to proceed for 14 h, after
hich the cells were fixed and the virus titer was deter-
ined by an immunoperoxidase focus assay (1). For the
ell-binding blocking assay, MA104 cells in suspension
ere preincubated with the MAbs to the different inte-
rins for 1 h at 4°C, and after the excess antibody was
emoved, 300 ng of CsCl-purified viruses nar3 or RRV
as added to the cells. After an incubation period of 1 h
t 4°C the cells were washed, and the cell-bound virus
as determined by ELISA (17).
As previously observed (8), the infectivity of RRV and
that of its variant nar3 were found to decrease 25 to 45%
when the cells were incubated with MAbs to integrins
a2, a4, and b2, while they were not affected by MAb
B12, directed against integrin subunit a1 (Fig. 1A). This
evel of inhibition is in accordance with that found by
oulson et al. (4) and Hewish et al. (9) for SA11 and RV5
otaviruses.
When the blocking activity of the integrin antibodies on
he binding of the viruses was analyzed, a differential
ffect on RRV and nar3 was observed. Although the
inding of RRV was not affected by any of the antibodies
ested, MAb P1E6 to integrin subunit a2 reduced the cell
attachment of nar3 by about 40%. The MAbs to the other
integrin subunits did not modify the binding of nar3 (Fig.
1B).
These results suggest that the MAb to integrin a2
locks the infectivity of RRV and nar3 through different
echanisms. It seems to inhibit the infectivity of nar3 by
reventing its attachment to the cell surface, while RRV
eems to be blocked at a postbinding step. Antibodies to
a4 and b2 integrins apparently inhibit a postattachment
interaction of both viruses.
We recently reported that the NA-resistant variant nar3
binds to the surface of MA104 cells through the VP5
domain of VP4 (17). Since VP5 contains the tripeptide-
recognition motif DGE for integrin a2b1, and a MAb to
the a2 integrin subunit blocks the binding of nar3 (Fig.
B), we hypothesized that this virus binds to cells
hrough the DGE motif, located at VP5 amino acid resi-
ues 308–310. To demonstrate the role of DGE in the
inding of VP5 to cells, we used a recombinant RRV
ST-VP5 fusion protein produced in bacteria, which was
reviously shown to bind specifically to MA104 cells (17).
n addition, two modified versions of this protein were
onstructed by site-directed mutagenesis. In one, the
spartic acid residue in the triplet DGE was replaced by
D308An alanine residue (GST-VP5 ). In the second, we
altered the sequence of the putative fusion peptidepresent in VP5 (13); the glycine residue at amino acid
position 400 was replaced by an aspartic acid, to yield
the mutant protein GST-VP5G400D.
Wild-type (wt) GST-VP5 and the mutant proteins were
xpressed in bacteria and affinity-purified essentially as
escribed by Isa et al. (10). To assay the ability of these
polypeptides to bind to the cell surface, different
amounts of each fusion protein were incubated with
MA104 cells for 1 h at 4°C, and the protein bound to cells
FIG. 1. Effect of MAbs to different integrin subunits on the infectivity
and binding of RRV and nar3 viruses. (A) MA104 cells in 96-well plates
were preincubated for 1 h at 37°C, with MAbs to integrin subunits a2,
b2, a4, or a1; after incubation with antibody the cells were washed
wice with MEM, and then RRV or nar3 viruses (2000 FFUs per well)
ere adsorbed for 60 min at 4°C; after the adsorption period the
noculum was removed and the infection was allowed to proceed for
4 h at 37°C, after which the cells were fixed and immunostained. Data
re expressed as the percentage of the virus infectivity obtained when
he cells were preincubated with MEM as control. (B) MA104 cells in
uspension (5 3 104 cells/assay) were preincubated with MAbs to
integrins a2, b2, and a4 for 1 h at 4°C. The excess, unbound antibody
as removed, and then 300 ng of either RRV or nar3 purified virus
articles was added, and the mixture was further incubated for 1 h at
°C. The amount of virus bound to cells was determined by an ELISA
s described (17). Data are expressed as the percentage of the virus
inding obtained when the cells were preincubated with PBS as a
ontrol. The bars represent the standard error of at least three inde-
endent experiments performed in duplicate. The antibodies used
ere MAb P1E6 (3.2 mg/ml) to a2, MHM23 (41 mg/ml) to b2, P4G9 (8.1
mg/ml) to a4, and FB12 (10 mg/ml) to a1.was determined by ELISA (17). The inset to Fig. 2 shows

























52 RAPID COMMUNICATIONteins was very similar to that found for wt GST-VP5,
indicating that the changes introduced did not impair the
ability of the mutagenized polypeptides to attach to
MA104 cells.
We previously described that the wt GST-VP5 protein is
able to efficiently compete the binding of nar3, but not
that of RRV (17); thus, we assayed the ability of both
mutant proteins to compete the binding of RRV and nar3.
For this, purified viruses were added to MA104 cells,
which were previously incubated with different amounts
of each recombinant protein for 1 h at 4°C. The virus that
remained bound to the cells was determined as de-
scribed above. While the GST-VP5G400D protein competed
he binding of nar3 as efficiently as did wt GST-VP5, the
ST-VP5D308A polypeptide did not affect the attachment of
the virus at any of the concentrations used (Fig. 2). As
expected, the attachment of RRV was not affected by any
of the recombinant proteins tested (Fig. 2, shown only for
the highest concentration of the proteins). These results
suggest that binding through the DGE integrin motif is
required for the GST-VP5 protein to compete the attach-
ment of the variant nar3. On the other hand, the fusion
peptide region of VP5 does not seem to be important for
the binding of this virus, since the mutant GST-VP5G400D
FIG. 2. Effect of recombinant proteins GST-VP5, GST-VP5G400D, and
ST-VP5D308A on the binding of RRV and nar3 viral particles to MA104
cells. The indicated amounts of affinity-purified fusion proteins were
preincubated with 5 3 104 MA104 cells in suspension for 1 h at 4°C.
fter the excess protein was removed, 300 ng of either RRV (closed
ymbols) or nar3 (open symbols) purified viral particles was added, and
he mixture was further incubated for 1 h at 4°C. The amount of virus
r fusion proteins that remained bound to the cells was determined by
n ELISA. The total amount of recombinant protein added to each
ssay is plotted against the OD405 readings obtained in the ELISA plate
(shown in the inset). The amount of cell-bound virus particles is ex-
pressed as the percentage of the virus binding obtained when the cells
were preincubated with PBS as a control. The arithmetic means 6
standard error from two independent experiments performed in dupli-
cate are shown. For RRV virus only the highest amount of each recom-
binant protein was tested.retained its ability to block the attachment of the virus.
The fact that the GST-VP5D308A recombinant protein was
c
bnot able to compete the binding of nar3, even though it
binds to the cell surface as efficiently as wt GST-VP5,
suggests the existence of an additional attachment site
in VP5, independent of the DGE motif, and also probably
independent of the integrin-recognition motif IDA present
at residues 538–540 of VP5 (4), since the MAb to a4 did
not affect the binding of nar3 (Fig. 1B). The possibility that
GST-VP5D308A might bind to the cell surface in a nonspe-
ific manner, however, cannot be ruled out.
We also studied the effect of synthetic peptides that
imic different regions of VP5 on the infectivity and
inding of nar3 and RRV. The peptides tested comprised
mino acids 297 to 318, which contain the a2 integrin-
inding site (peptide DGE); amino acids 380 to 401, which
ontain the putative fusion region of the protein (peptide
P); or amino acids 738 to 754 from the carboxy-terminal
egion of VP5 (peptide COOH). The ability of these pep-
ides to block the infectivity and binding of the viruses
as tested by preincubation of MA104 cells with 8 mg/ml
of each peptide before addition of the virus. As shown in
Fig. 3, peptide DGE was found to block the infectivity of
both RRV and nar3 by about 40 and 70%, respectively,
although it inhibited the binding only of the latter virus.
Peptide FP also blocked the infectivity of both viruses,
although to a lesser extent than did peptide DGE, and it
did not affect, or only slightly affected, the binding of nar3
and RRV. Peptide COOH, which was used as a negative
control, did not affect either the infectivity or the binding
of the viruses. These results are consistent with the idea
that the DGE motif present in VP5 is relevant for the initial
binding of the nar3 variant, while it is not used by wt RRV
to initially attach to the cells. The block in the infectivity
of RRV caused by peptide DGE is again, most probably,
at a postattachment step.
The inhibitory effect that peptide FP has on the viral
infectivity of both RRV and nar3 viruses could be the
result of a direct interaction of the peptide with the cell
membrane, which in turn interferes with the virus infec-
tion at some point after the initial binding of the viruses
to the cell surface. Recently, Dowling et al. (5) showed
that mutations in this region of VP5 abrogate the mem-
brane permeabilization activity of the protein. Our obser-
vation that a peptide that mimics the fusion peptide of
VP5 is able to block the infectivity of rotaviruses at a
postbinding step is in accordance with their findings.
Taken together, these results indicate that the NA-
resistant variant nar3 binds to the surface of MA104 cells
by interacting with the a2b1 integrin through the DGE
otif of VP5, while RRV interacts with this integrin after
ts initial binding to the cell surface with an as yet
ndetermined SA-containing receptor.
Recently, Hewish et al. (9) found that K562 cells, trans-
ected with the genes for either a2 or a4 integrin sub-
nits, bound more rotavirus SA11 than did untransfected
ells, and this increased binding was blocked by anti-

































53RAPID COMMUNICATIONbinding assay, in which the K562-cell-bound virus was
recovered by freeze–thawing of the cells and subse-
quently titered in MA104 cells, was used. In contrast to
those results we found that antibodies to either a2 or a4
ere not able to prevent the binding of the simian rota-
irus RRV, which shares with SA11 not only the VP7
erotype but also its dependence on SA to infect cells.
his discrepancy in the role of integrin subunits a2 and
a4 as attachment receptors for SA-dependent viruses
might be explained by the different binding assays used,
the different cell lines employed, or the different rotavirus
FIG. 3. Effect of synthetic peptides on the infectivity and binding of
RRV and nar3 viruses. (A) MA104 cells in 96-well plates were preincu-
bated for 1 h at 37°C with 8 mg/ml of each peptide, and then RRV or
nar3 viruses (2000 FFUs per well) were adsorbed for 1 h at 4°C; after
the adsorption period the inoculum was removed and the infection was
allowed to proceed for 14 h at 37°C, after which the cells were fixed
and immunostained. Data are expressed as percentage of the virus
infectivity obtained when the cells were preincubated with MEM as
control. The bars represent the standard error of two independent
experiments performed in duplicate. (B) MA104 cells in suspension
(5 3 104 cells per assay) were preincubated with 4 mg/ml of each
eptide for 1 h at 4°C. The excess peptide was removed, the cells were
ashed, and 300 ng of either RRV or nar3 viral particles was added.
he mixture was incubated for 1 h at 4°C and the amount of virus
ound to the cell was determined by an ELISA. Data are expressed as
he percentage of the virus bound to the cells when they were prein-
ubated with PBS as a control. The bars represent the standard error
f two independent experiments performed in duplicate.strains characterized.
We recently described that the binding of both thevariant nar3 and the wt GST-VP5 protein is partially in-
hibited by monoclonal antibody 2D9, which is directed to
an as yet unknown molecule on the surface of MA104
cells (11). Even though the behavior of MAb 2D9 is
similar to that of the a2 integrin antibody, 2D9 is probably
not directed to this integrin, since its pattern of staining
of mouse small intestinal cells is quite different from that
obtained with a MAb to a2 (unpublished data). Never-
theless, the cell structure recognized by 2D9 must be in
close proximity to integrin a2b1 on the surface of MA104
ells, since MAb 2D9 displaces the binding of antibodies
o a2 by flow cytometry (Isa et al., unpublished results).
Thus, the antigen recognized by 2D9 might serve as an
alternative cell receptor for the variant nar3, since cells
that lack a2b1 but are 2D9-positive, like L or CHO cells
11), can be infected by this virus, albeit with much lower
fficiency.
We proposed a model for the early interactions of
nimal rotaviruses with MA104 cells, in which we sug-
ested that RRV initially binds to an as yet unidentified
A-containing compound in the cell membrane through
he VP8 domain of VP4. Subsequent to this initial inter-
ction we proposed that the virus interacts with a sec-
nd, SA-independent, cell receptor through the VP5 do-
ain of VP4, and we also hypothesized that the NA-
esistant variant nar3 interacts directly through VP5 with
he second receptor (17). In this work we identified this
econd receptor as integrin a2b1.
The results reported here further support our hypoth-
esis that the interaction of rotaviruses with their host cell
is a multistep process in which sequential contacts of
the viral capsid with the cell surface take place (15).
hese multiple interactions of viruses with cell receptors
ave been observed for different viruses, such as HIV,
denovirus, measles virus, and herpes simplex virus (16).
n the case of rotaviruses, how many more contacts the
irus has with the cell surface before it reaches the cell’s
ytoplasm and which cellular and viral partners are in-
olved in these interactions remain to be determined.
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